Concepts (197)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| B-Lymphocytes, Regulatory | 1 | 2017 | 24 | 0.68 | Why? |
| Peyer's Patches | 1 | 2008 | 27 | 0.39 | Why? |
| Viruses | 2 | 2021 | 2238 | 0.38 | Why? |
| Adaptive Immunity | 1 | 2021 | 2585 | 0.38 | Why? |
| Respiratory Tract Infections | 3 | 2021 | 6817 | 0.31 | Why? |
| Hemagglutination Tests | 1 | 2021 | 124 | 0.21 | Why? |
| Gastrointestinal Tract | 1 | 2008 | 1113 | 0.21 | Why? |
| United Kingdom | 16 | 2021 | 18046 | 0.20 | Why? |
| Genetic Fitness | 1 | 2021 | 339 | 0.18 | Why? |
| Clinical Protocols | 4 | 2021 | 2734 | 0.17 | Why? |
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2020 | 290 | 0.17 | Why? |
| Clinical Deterioration | 1 | 2021 | 473 | 0.16 | Why? |
| Hospital Mortality | 8 | 2021 | 22087 | 0.14 | Why? |
| Hospitalization | 9 | 2021 | 54280 | 0.14 | Why? |
| Pneumothorax | 1 | 2021 | 758 | 0.12 | Why? |
| Musculoskeletal Diseases | 1 | 2020 | 646 | 0.12 | Why? |
| Immunologic Memory | 2 | 2021 | 3362 | 0.11 | Why? |
| World Health Organization | 5 | 2021 | 4213 | 0.11 | Why? |
| Respirovirus Infections | 1 | 1991 | 90 | 0.10 | Why? |
| Immune Evasion | 1 | 2021 | 2081 | 0.10 | Why? |
| Minority Groups | 1 | 2021 | 1631 | 0.10 | Why? |
| Rheumatology | 1 | 2020 | 1213 | 0.10 | Why? |
| Lung Diseases, Interstitial | 1 | 2020 | 1476 | 0.10 | Why? |
| CD4-Positive T-Lymphocytes | 3 | 2021 | 4545 | 0.10 | Why? |
| Cross Reactions | 1 | 2021 | 4374 | 0.10 | Why? |
| T-Lymphocytes | 2 | 2021 | 6670 | 0.10 | Why? |
| Fungi | 1 | 2012 | 471 | 0.09 | Why? |
| Critical Care | 6 | 2021 | 14081 | 0.09 | Why? |
| Asthma | 2 | 2021 | 4383 | 0.09 | Why? |
| Blood Coagulation Disorders | 1 | 2021 | 2040 | 0.09 | Why? |
| CD8-Positive T-Lymphocytes | 3 | 2021 | 5837 | 0.08 | Why? |
| Enteritis | 1 | 2008 | 147 | 0.08 | Why? |
| Internationality | 1 | 2020 | 3297 | 0.08 | Why? |
| Respiratory Syncytial Viruses | 1 | 1991 | 612 | 0.08 | Why? |
| Clinical Decision-Making | 1 | 2021 | 3755 | 0.08 | Why? |
| Tracheostomy | 1 | 2020 | 1963 | 0.08 | Why? |
| Virus Diseases | 1 | 2004 | 3779 | 0.08 | Why? |
| Communicable Diseases, Emerging | 1 | 2020 | 2523 | 0.08 | Why? |
| Lung | 4 | 2020 | 31049 | 0.07 | Why? |
| Viral Vaccines | 2 | 2020 | 7560 | 0.07 | Why? |
| Humans | 34 | 2021 | 930598 | 0.07 | Why? |
| Receptors, Antigen, T-Cell | 1 | 1991 | 760 | 0.07 | Why? |
| Artificial Intelligence | 1 | 2020 | 3543 | 0.07 | Why? |
| Immunoassay | 1 | 2021 | 4485 | 0.07 | Why? |
| Hospitals | 2 | 2021 | 11793 | 0.07 | Why? |
| Comorbidity | 4 | 2021 | 34796 | 0.07 | Why? |
| Rheumatic Diseases | 1 | 2020 | 2675 | 0.07 | Why? |
| Coronavirus Infections | 11 | 2020 | 253789 | 0.07 | Why? |
| Immunologic Factors | 1 | 2020 | 4206 | 0.07 | Why? |
| Observational Studies as Topic | 2 | 2021 | 1887 | 0.07 | Why? |
| Respiration, Artificial | 4 | 2021 | 22116 | 0.06 | Why? |
| Obesity | 2 | 2021 | 7388 | 0.06 | Why? |
| Betacoronavirus | 9 | 2020 | 204454 | 0.06 | Why? |
| Pulmonary Eosinophilia | 1 | 2003 | 46 | 0.06 | Why? |
| Pulmonary Disease, Chronic Obstructive | 1 | 2021 | 3832 | 0.06 | Why? |
| Adenoviridae Infections | 1 | 2004 | 150 | 0.06 | Why? |
| Antigens, Viral | 1 | 2020 | 6298 | 0.06 | Why? |
| Influenza A Virus, H1N1 Subtype | 2 | 2021 | 2984 | 0.06 | Why? |
| Forecasting | 1 | 2017 | 4492 | 0.06 | Why? |
| Influenza, Human | 4 | 2021 | 10779 | 0.06 | Why? |
| Cryptococcosis | 1 | 2003 | 97 | 0.06 | Why? |
| Spike Glycoprotein, Coronavirus | 3 | 2021 | 37182 | 0.06 | Why? |
| Interferon-gamma | 2 | 2021 | 2711 | 0.06 | Why? |
| Cytokines | 2 | 2021 | 15010 | 0.06 | Why? |
| SARS Virus | 2 | 2020 | 13021 | 0.06 | Why? |
| Pneumonia, Viral | 11 | 2020 | 243684 | 0.06 | Why? |
| Dipeptidyl-Peptidases and Tripeptidyl-Peptidases | 1 | 2020 | 73 | 0.06 | Why? |
| Chromosomes, Human, Pair 19 | 1 | 2020 | 77 | 0.06 | Why? |
| Metapneumovirus | 1 | 2004 | 465 | 0.06 | Why? |
| Chromosomes, Human, Pair 12 | 1 | 2020 | 84 | 0.05 | Why? |
| Bacteria | 1 | 2012 | 1897 | 0.05 | Why? |
| Chromosomes, Human, Pair 21 | 1 | 2020 | 90 | 0.05 | Why? |
| Paramyxoviridae Infections | 1 | 2004 | 364 | 0.05 | Why? |
| TYK2 Kinase | 1 | 2020 | 116 | 0.05 | Why? |
| Receptors, CCR2 | 1 | 2020 | 103 | 0.05 | Why? |
| Agglutination Tests | 1 | 2021 | 124 | 0.05 | Why? |
| HIV Infections | 2 | 2021 | 11620 | 0.05 | Why? |
| Cohort Studies | 5 | 2021 | 36005 | 0.05 | Why? |
| Systemic Inflammatory Response Syndrome | 1 | 2020 | 6653 | 0.05 | Why? |
| Antibodies, Viral | 3 | 2021 | 51949 | 0.05 | Why? |
| 2',5'-Oligoadenylate Synthetase | 1 | 2020 | 205 | 0.05 | Why? |
| Multigene Family | 1 | 2020 | 377 | 0.05 | Why? |
| Age Factors | 4 | 2021 | 21039 | 0.05 | Why? |
| Cross Infection | 1 | 2021 | 8675 | 0.05 | Why? |
| Prospective Studies | 5 | 2021 | 43301 | 0.05 | Why? |
| Sequence Analysis | 1 | 2020 | 496 | 0.05 | Why? |
| Histones | 1 | 2021 | 371 | 0.05 | Why? |
| DNA, Complementary | 1 | 2020 | 568 | 0.05 | Why? |
| Receptor, Interferon alpha-beta | 1 | 2020 | 610 | 0.05 | Why? |
| Vaccines | 1 | 2017 | 3692 | 0.04 | Why? |
| Aged | 11 | 2021 | 215776 | 0.04 | Why? |
| Common Cold | 1 | 2004 | 645 | 0.04 | Why? |
| Female | 15 | 2021 | 380317 | 0.04 | Why? |
| Time Factors | 1 | 2021 | 31397 | 0.04 | Why? |
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 9706 | 0.04 | Why? |
| Male | 13 | 2021 | 367725 | 0.04 | Why? |
| Critical Illness | 1 | 2020 | 17281 | 0.04 | Why? |
| Tomography, X-Ray Computed | 2 | 2020 | 25144 | 0.04 | Why? |
| Pandemics | 14 | 2021 | 389249 | 0.04 | Why? |
| Middle Aged | 10 | 2021 | 270681 | 0.04 | Why? |
| Practice Guidelines as Topic | 1 | 2020 | 15421 | 0.04 | Why? |
| Immunodominant Epitopes | 1 | 2020 | 813 | 0.04 | Why? |
| Bacterial Infections | 1 | 2008 | 2229 | 0.04 | Why? |
| Molecular Epidemiology | 1 | 2020 | 1638 | 0.03 | Why? |
| Respiratory Syncytial Virus Infections | 1 | 2004 | 1234 | 0.03 | Why? |
| HIV | 1 | 2021 | 1116 | 0.03 | Why? |
| Program Development | 1 | 2020 | 1089 | 0.03 | Why? |
| HIV-1 | 1 | 2008 | 3365 | 0.03 | Why? |
| Virulence | 1 | 2021 | 2172 | 0.03 | Why? |
| Europe | 2 | 2020 | 12702 | 0.03 | Why? |
| Cell Proliferation | 1 | 2021 | 1973 | 0.03 | Why? |
| Aged, 80 and over | 5 | 2021 | 88759 | 0.03 | Why? |
| Genome-Wide Association Study | 1 | 2020 | 1648 | 0.03 | Why? |
| Vaccination | 2 | 2017 | 19050 | 0.03 | Why? |
| Respiratory Tract Diseases | 1 | 2021 | 1061 | 0.03 | Why? |
| Severe Acute Respiratory Syndrome | 2 | 2008 | 12361 | 0.03 | Why? |
| BCG Vaccine | 1 | 2003 | 1137 | 0.03 | Why? |
| Multiplex Polymerase Chain Reaction | 1 | 2020 | 1439 | 0.03 | Why? |
| Infant | 3 | 2020 | 30274 | 0.03 | Why? |
| Diagnostic Imaging | 1 | 2020 | 1044 | 0.03 | Why? |
| Disease Progression | 2 | 2020 | 13580 | 0.03 | Why? |
| Neoplasms | 1 | 2020 | 17251 | 0.03 | Why? |
| CD8 Antigens | 1 | 1991 | 72 | 0.03 | Why? |
| Adolescent | 5 | 2021 | 86841 | 0.03 | Why? |
| Immunomodulation | 1 | 2020 | 1472 | 0.03 | Why? |
| Child, Preschool | 3 | 2020 | 36283 | 0.03 | Why? |
| Seroconversion | 1 | 2021 | 2515 | 0.03 | Why? |
| Antigens, Differentiation, T-Lymphocyte | 1 | 1991 | 146 | 0.03 | Why? |
| CD3 Complex | 1 | 1991 | 237 | 0.03 | Why? |
| DNA, Viral | 1 | 2020 | 2521 | 0.03 | Why? |
| CD4 Antigens | 1 | 1991 | 306 | 0.02 | Why? |
| Young Adult | 4 | 2021 | 93724 | 0.02 | Why? |
| Odds Ratio | 1 | 2021 | 5861 | 0.02 | Why? |
| Epitopes, T-Lymphocyte | 1 | 2020 | 2262 | 0.02 | Why? |
| Flow Cytometry | 2 | 2003 | 2393 | 0.02 | Why? |
| Infant, Newborn | 2 | 2020 | 23105 | 0.02 | Why? |
| Peptides | 1 | 2021 | 2513 | 0.02 | Why? |
| High-Throughput Nucleotide Sequencing | 1 | 2020 | 3633 | 0.02 | Why? |
| Blood Coagulation | 1 | 2021 | 2768 | 0.02 | Why? |
| ROC Curve | 1 | 2020 | 6024 | 0.02 | Why? |
| Inflammation | 2 | 2021 | 13255 | 0.02 | Why? |
| Antiviral Agents | 1 | 2021 | 41703 | 0.02 | Why? |
| Adult | 6 | 2021 | 244371 | 0.02 | Why? |
| Acute Disease | 1 | 2020 | 6029 | 0.02 | Why? |
| HEK293 Cells | 1 | 2021 | 8394 | 0.02 | Why? |
| Point-of-Care Systems | 1 | 2021 | 2955 | 0.02 | Why? |
| Prognosis | 2 | 2021 | 32490 | 0.02 | Why? |
| Chronic Disease | 1 | 2021 | 5139 | 0.02 | Why? |
| Risk Assessment | 2 | 2021 | 25439 | 0.02 | Why? |
| Pregnancy Complications, Infectious | 1 | 2012 | 11559 | 0.02 | Why? |
| New York City | 1 | 2020 | 7432 | 0.02 | Why? |
| Severity of Illness Index | 3 | 2021 | 48226 | 0.02 | Why? |
| Polymerase Chain Reaction | 1 | 2021 | 6740 | 0.02 | Why? |
| Survival Rate | 1 | 2020 | 9206 | 0.02 | Why? |
| Logistic Models | 1 | 2021 | 9089 | 0.02 | Why? |
| Enzyme-Linked Immunosorbent Assay | 1 | 2021 | 7868 | 0.02 | Why? |
| Databases, Factual | 1 | 2020 | 6248 | 0.02 | Why? |
| Predictive Value of Tests | 1 | 2020 | 9537 | 0.02 | Why? |
| Glucocorticoids | 1 | 2020 | 4431 | 0.02 | Why? |
| Reproducibility of Results | 1 | 2021 | 11304 | 0.02 | Why? |
| Patient Admission | 1 | 2021 | 5250 | 0.02 | Why? |
| Societies, Medical | 1 | 2020 | 6907 | 0.02 | Why? |
| Radiography, Thoracic | 1 | 2020 | 5486 | 0.02 | Why? |
| Interleukin-5 | 1 | 2003 | 138 | 0.02 | Why? |
| Clinical Laboratory Techniques | 2 | 2020 | 23402 | 0.02 | Why? |
| Sex Factors | 1 | 2020 | 11014 | 0.02 | Why? |
| Nervous System Diseases | 1 | 2021 | 4092 | 0.01 | Why? |
| Adoptive Transfer | 1 | 2003 | 250 | 0.01 | Why? |
| Phylogeny | 1 | 2021 | 13341 | 0.01 | Why? |
| Drug Repositioning | 1 | 2020 | 5683 | 0.01 | Why? |
| Antibodies, Monoclonal | 1 | 2021 | 8041 | 0.01 | Why? |
| Immunosuppressive Agents | 1 | 2020 | 6331 | 0.01 | Why? |
| Interleukin-4 | 1 | 2003 | 367 | 0.01 | Why? |
| Real-Time Polymerase Chain Reaction | 1 | 2020 | 11367 | 0.01 | Why? |
| Child | 2 | 2020 | 70012 | 0.01 | Why? |
| Mutation | 1 | 2021 | 12376 | 0.01 | Why? |
| Mice, Inbred BALB C | 1 | 1991 | 5814 | 0.01 | Why? |
| Sensitivity and Specificity | 1 | 2021 | 22971 | 0.01 | Why? |
| Th2 Cells | 1 | 2003 | 680 | 0.01 | Why? |
| Coronavirus | 1 | 2008 | 18339 | 0.01 | Why? |
| Epithelial Cells | 1 | 1991 | 3508 | 0.01 | Why? |
| Genome, Viral | 1 | 2020 | 13157 | 0.01 | Why? |
| Mice | 2 | 2003 | 21357 | 0.01 | Why? |
| Immunoglobulin G | 1 | 2021 | 21571 | 0.01 | Why? |
| Cardiovascular Diseases | 1 | 2021 | 11497 | 0.01 | Why? |
| Intensive Care Units | 1 | 2021 | 29594 | 0.01 | Why? |
| Antibodies, Neutralizing | 1 | 2021 | 25288 | 0.01 | Why? |
| Global Health | 1 | 2017 | 13911 | 0.01 | Why? |
| Case-Control Studies | 1 | 2012 | 17671 | 0.01 | Why? |
| RNA, Viral | 1 | 2020 | 32276 | 0.01 | Why? |
| Mice, Inbred C57BL | 1 | 2003 | 5542 | 0.01 | Why? |
| Risk Factors | 1 | 2020 | 71621 | 0.01 | Why? |
| Health Personnel | 1 | 2021 | 29646 | 0.01 | Why? |
| Prevalence | 1 | 2012 | 25773 | 0.01 | Why? |
| Pregnancy | 1 | 2012 | 23879 | 0.01 | Why? |
| Retrospective Studies | 1 | 2020 | 105322 | 0.01 | Why? |
| Animals | 2 | 2003 | 78931 | 0.01 | Why? |
Openshaw's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(197)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(592)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_